This is a preview of subscription content, log in via an institution to check access.
Notes
see Reactions 1649 p6; 803239581
Reference
US Food and Drug Administration. FDA acts to protect kids from serious risks of opioid ingredients contained in some prescription cough and cold products by revising labeling to limit pediatric use. Internet Document : 11 Jan 2018. Available from: URL: https://www.fda.gov/NewsEvents/Newsroom/PressAnnouncements/ucm592109.htm
Rights and permissions
About this article
Cite this article
US FDA restricts use of opioid products for coughs/colds. Reactions Weekly 1686, 9 (2018). https://doi.org/10.1007/s40278-018-41073-6
Published:
Issue Date:
DOI: https://doi.org/10.1007/s40278-018-41073-6